Contract 36F79725D0024
Currax Pharmaceuticals Llc · Department Of Veterans Affairs · November 26, 2024
Currax Pharmaceuticals Llc was awarded a federal contract by Department Of Veterans Affairs on November 26, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 4 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on October 23, 2025. If all options are exercised, the contract could reach $225,000.
Contract details
- PIID
- 36F79725D0024
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- November 26, 2024
- Latest action
- October 23, 2025
Description
ADMINISTRATIVE CHANGE
Modification timeline
-
October 23, 2025Mod P00004$0
-
July 2, 2025Mod P00003ESTABLISHING DUAL PRICING$0
-
April 24, 2025Mod P00002ADMINISTRATIVE CHANGE OF POINTS OF CONTACT$0
-
December 10, 2024Mod P000012025 PUBLIC LAW PRICING UPDATE$0
-
November 26, 2024Base award65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79725D0024?
Contract 36F79725D0024 is a federal contract awarded to Currax Pharmaceuticals Llc by Department Of Veterans Affairs on November 26, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 4 times since the base award.
Who won contract 36F79725D0024?
Currax Pharmaceuticals Llc won contract 36F79725D0024 from Department Of Veterans Affairs.
How much is contract 36F79725D0024 worth?
Contract 36F79725D0024 has obligated $0 to date but carries a potential ceiling of $225,000 if fully funded and all options are exercised.